About
VemiCo Ltd develops postbiotic bioactive compounds that strengthen gut barrier function and enhance immune resilience by targeting the host's innate ability to adapt, rather than modifying microbiome composition.
Explore VemiCo Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.